These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1330587

  • 1. In vivo binding of N1'-([11C]methyl)naltrindole to delta-opioid receptors in mouse brain.
    Lever JR, Scheffel U, Kinter CM, Ravert HT, Dannals RF, Wagner HN, Frost JJ.
    Eur J Pharmacol; 1992 Jun 17; 216(3):459-60. PubMed ID: 1330587
    [Abstract] [Full Text] [Related]

  • 2. Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.
    Madar I, Lever JR, Kinter CM, Scheffel U, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.
    Synapse; 1996 Sep 17; 24(1):19-28. PubMed ID: 9046073
    [Abstract] [Full Text] [Related]

  • 3. In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype.
    Lever JR, Stathis M, Kinter CM, Scheffel U.
    Life Sci; 1996 Sep 17; 58(21):PL331-6. PubMed ID: 8637403
    [Abstract] [Full Text] [Related]

  • 4. Quantification of delta-opioid receptors in human brain with N1'-([11C]methyl) naltrindole and positron emission tomography.
    Smith JS, Zubieta JK, Price JC, Flesher JE, Madar I, Lever JR, Kinter CM, Dannals RF, Frost JJ.
    J Cereb Blood Flow Metab; 1999 Sep 17; 19(9):956-66. PubMed ID: 10478647
    [Abstract] [Full Text] [Related]

  • 5. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
    Contreras PC, Tam L, Drower E, Rafferty MF.
    Brain Res; 1993 Feb 26; 604(1-2):160-4. PubMed ID: 8384509
    [Abstract] [Full Text] [Related]

  • 6. An updated synthesis of N1 '-([11 C]methyl)naltrindole for positron emission tomography imaging of the delta opioid receptor.
    Kaur T, Brooks AF, Hockley BG, Torres J, Henderson BD, Scott PJH, Shao X.
    J Labelled Comp Radiopharm; 2021 Apr 26; 64(4):187-193. PubMed ID: 33274468
    [Abstract] [Full Text] [Related]

  • 7. Characterization of [3H]naltrindole binding to delta opioid receptors in rat brain.
    Yamamura MS, Horvath R, Toth G, Otvos F, Malatynska E, Knapp RJ, Porreca F, Hruby VJ, Yamamura HI.
    Life Sci; 1992 Apr 26; 50(16):PL119-24. PubMed ID: 1313133
    [Abstract] [Full Text] [Related]

  • 8. N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands.
    Tyacke RJ, Robinson ES, Schnabel R, Lewis JW, Husbands SM, Nutt DJ, Hudson AL.
    Nucl Med Biol; 2002 May 26; 29(4):455-62. PubMed ID: 12031880
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S, Johnson CA, Carter RL, Clayton SD, Rice KC, Xu H, Davis P, Porreca F, Rothman RB.
    J Med Chem; 1998 Jul 16; 41(15):2872-81. PubMed ID: 9667975
    [Abstract] [Full Text] [Related]

  • 10. PET imaging of human cardiac opioid receptors.
    Villemagne PS, Dannals RF, Ravert HT, Frost JJ.
    Eur J Nucl Med Mol Imaging; 2002 Oct 16; 29(10):1385-8. PubMed ID: 12271423
    [Abstract] [Full Text] [Related]

  • 11. Quantitative light microscopic localization of [3H]naltrindole binding sites in the rat brain.
    Drower EJ, Dorn CR, Markos CS, Unnerstall JR, Rafferty MF, Contreras PC.
    Brain Res; 1993 Jan 29; 602(1):138-42. PubMed ID: 8383568
    [Abstract] [Full Text] [Related]

  • 12.
    Leung K.
    ; 2004 Jan 29. PubMed ID: 20641218
    [Abstract] [Full Text] [Related]

  • 13. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography.
    Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.
    Ann Neurol; 1997 Mar 29; 41(3):358-67. PubMed ID: 9066357
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
    Fang L, Knapp RJ, Horvath R, Matsunaga TO, Haaseth RC, Hruby VJ, Porreca F, Yamamura HI.
    J Pharmacol Exp Ther; 1994 Feb 29; 268(2):836-46. PubMed ID: 8113996
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Localization of opioid receptor antagonist [3H]-LY255582 binding sites in mouse brain: comparison with the distribution of mu, delta and kappa binding sites.
    Gackenheimer SL, Suter TM, Pintar JE, Quimby SJ, Wheeler WJ, Mitch CH, Gehlert DR, Statnick MA.
    Neuropeptides; 2005 Dec 29; 39(6):559-67. PubMed ID: 16289278
    [Abstract] [Full Text] [Related]

  • 19. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 29; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 20. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S, Khare NK, Saini SK, Seitz LE, Bartlett JL, Davis P, Dersch CM, Porreca F, Rothman RB, Bilsky EJ.
    J Med Chem; 2004 Mar 11; 47(6):1400-12. PubMed ID: 14998329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.